PLG Q4 2023 Earnings EPS Beat Masks Continued PreRevenue Stage as Stock Declines CSPI Q1 2026 Earnings Modest EPS of 003 Drives Stock Gains Disc Medicine Q1 2026 Earnings Narrowed Loss Beats Estimates as Biotech Advances Hematology Pipeline NATR Q1 2026 Earnings Strong EPS Surprise Amid Quiet Revenue Disclosures QMCO Q1 2026 Earnings EPS Beats Estimates by 216 Stock Gains FMAO Q1 2026 Earnings EPS Surpasses Estimates Amidst Challenging Interest Rate Environment